New challenges in viral hepatitis
Identifieur interne : 000177 ( France/Analysis ); précédent : 000176; suivant : 000178New challenges in viral hepatitis
Auteurs : David Thomas [États-Unis] ; Fabien Zoulim [France]Source :
- Gut [ 0017-5749 ] ; 2012-05.
English descriptors
- Teeft :
- Adverse events, Antiviral, Antiviral therapy, Chronic hepatitis, Chronic infection, Effective vaccines, Engl, Epigenetic regulation, Exciting developments, General population, Global burden, Hepatitis, Hepatitis viruses, Hepatocellular carcinoma, Infection, Infectious diseases, Injection safety, Johns hopkins school, Lancet, Major future challenge, Nucleoside analogues, Pegylated interferon, Preventable causes, Protease inhibitors, Public health impact, Risk factors, Vaccination, Vaccine, Viral, Viral hepatitis, Viral replication, Virus, Virus infection, Virus infections, Zoonotic transmission.
Abstract
Over the past few decades there has been remarkable progress in viral hepatitis. Beginning with discovery of the viral agents, we now have reliable methods to diagnose and monitor all hepatitis virus infections, as well significant advances in treatment and prevention. Nonetheless, important challenges remain. This supplement to Gut looks forward to the next generation of challenges in the field of viral hepatitis, and this introductory article highlights several key issues.
Url:
DOI: 10.1136/gutjnl-2012-302122
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001995
- to stream Istex, to step Curation: 001995
- to stream Istex, to step Checkpoint: 000485
- to stream Main, to step Merge: 001E00
- to stream Main, to step Curation: 001D76
- to stream Main, to step Exploration: 001D76
- to stream France, to step Extraction: 000177
Links to Exploration step
ISTEX:20F5B26A4BD2D39887AD95ECA1B75B785FEBCCFELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>New challenges in viral hepatitis</title><author><name sortKey="Thomas, David" sort="Thomas, David" uniqKey="Thomas D" first="David" last="Thomas">David Thomas</name></author><author><name sortKey="Zoulim, Fabien" sort="Zoulim, Fabien" uniqKey="Zoulim F" first="Fabien" last="Zoulim">Fabien Zoulim</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:20F5B26A4BD2D39887AD95ECA1B75B785FEBCCFE</idno><date when="2012" year="2012">2012</date><idno type="doi">10.1136/gutjnl-2012-302122</idno><idno type="url">https://api.istex.fr/ark:/67375/NVC-LNLXFF13-D/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001995</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001995</idno><idno type="wicri:Area/Istex/Curation">001995</idno><idno type="wicri:Area/Istex/Checkpoint">000485</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000485</idno><idno type="wicri:doubleKey">0017-5749:2012:Thomas D:new:challenges:in</idno><idno type="wicri:Area/Main/Merge">001E00</idno><idno type="wicri:Area/Main/Curation">001D76</idno><idno type="wicri:Area/Main/Exploration">001D76</idno><idno type="wicri:Area/France/Extraction">000177</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">New challenges in viral hepatitis</title><author><name sortKey="Thomas, David" sort="Thomas, David" uniqKey="Thomas D" first="David" last="Thomas">David Thomas</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country></affiliation></author><author><name sortKey="Zoulim, Fabien" sort="Zoulim, Fabien" uniqKey="Zoulim F" first="Fabien" last="Zoulim">Fabien Zoulim</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Lyon University, Institut Universitaire de France</wicri:regionArea><wicri:noRegion>Institut Universitaire de France</wicri:noRegion><wicri:noRegion>Institut Universitaire de France</wicri:noRegion></affiliation><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>INSERM U1052, Viral Hepatitis Research Team, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Gut</title><title level="j" type="abbrev">Gut</title><idno type="ISSN">0017-5749</idno><idno type="eISSN">1468-3288</idno><imprint><publisher>BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><date type="published" when="2012-05">2012-05</date><biblScope unit="volume">61</biblScope><biblScope unit="issue">Suppl 1</biblScope><biblScope unit="page" from="1">i1</biblScope></imprint><idno type="ISSN">0017-5749</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0017-5749</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Adverse events</term><term>Antiviral</term><term>Antiviral therapy</term><term>Chronic hepatitis</term><term>Chronic infection</term><term>Effective vaccines</term><term>Engl</term><term>Epigenetic regulation</term><term>Exciting developments</term><term>General population</term><term>Global burden</term><term>Hepatitis</term><term>Hepatitis viruses</term><term>Hepatocellular carcinoma</term><term>Infection</term><term>Infectious diseases</term><term>Injection safety</term><term>Johns hopkins school</term><term>Lancet</term><term>Major future challenge</term><term>Nucleoside analogues</term><term>Pegylated interferon</term><term>Preventable causes</term><term>Protease inhibitors</term><term>Public health impact</term><term>Risk factors</term><term>Vaccination</term><term>Vaccine</term><term>Viral</term><term>Viral hepatitis</term><term>Viral replication</term><term>Virus</term><term>Virus infection</term><term>Virus infections</term><term>Zoonotic transmission</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Over the past few decades there has been remarkable progress in viral hepatitis. Beginning with discovery of the viral agents, we now have reliable methods to diagnose and monitor all hepatitis virus infections, as well significant advances in treatment and prevention. Nonetheless, important challenges remain. This supplement to Gut looks forward to the next generation of challenges in the field of viral hepatitis, and this introductory article highlights several key issues.</div></front></TEI><affiliations><list><country><li>France</li><li>États-Unis</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Maryland</li><li>Rhône-Alpes</li></region><settlement><li>Lyon</li></settlement></list><tree><country name="États-Unis"><region name="Maryland"><name sortKey="Thomas, David" sort="Thomas, David" uniqKey="Thomas D" first="David" last="Thomas">David Thomas</name></region><name sortKey="Thomas, David" sort="Thomas, David" uniqKey="Thomas D" first="David" last="Thomas">David Thomas</name></country><country name="France"><noRegion><name sortKey="Zoulim, Fabien" sort="Zoulim, Fabien" uniqKey="Zoulim F" first="Fabien" last="Zoulim">Fabien Zoulim</name></noRegion><name sortKey="Zoulim, Fabien" sort="Zoulim, Fabien" uniqKey="Zoulim F" first="Fabien" last="Zoulim">Fabien Zoulim</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000177 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000177 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:20F5B26A4BD2D39887AD95ECA1B75B785FEBCCFE
|texte= New challenges in viral hepatitis
}}
| This area was generated with Dilib version V0.6.33. |  |